follows: Baht’000 Consolidated F/S ∆% Separate F/S ∆% 2019 2018 2019 2018 Revenues from Sales and Services 1,921,477 2,060,114 -7% 1,518,926 1,640,996 -7% Other income 72,604 338,396 -79% 52,158 25,568 104
Agreement and the Shareholders Agreement; and the capital increase of the Subsidiary from THB 556,536,900 to THB 1,112,851,210 by issuing 53,360,768 ordinary shares and 2,270,663 preferred shares, having a
พนัธ์สินคา้ ค่าตอบแทนท่ีจ่ายใหซิ้ลลิคฟาร์มาจากการว่าจา้งใหด้าํเนินการตาม Distribution Agreement และค่าตอบแทนการขายผลิตภณัฑข์องบริษทัในช่องทางร้านขายยาอิสระจาํนวนรวมประมาณ 4.99 ลา้น บาท เพิ่มข้ึนจากงวดเดีย
an unfavorable condition of the Company’s traditional trade channel because of the terminated contract with the distributor, which was effective since 30 June 2019. Further in this year, the period
May 12, 2020 has resolved to approve the Company’s subsidiary, Cal- Comp Precision Holding Co., Ltd.’s (“CCPT-KY”) initial public offering plan (the “IPO Plan”) to be listed in the Taiwan Stock Exchange
trade accounts payable. and the company has a list of liabilities under the lease agreement. Coming into the financial statements this year According to the financial reporting standard No. 1 6 , it has
liabilities, net of current portion of Baht 124.83 million consisted of lease agreement at the amount of Baht 121.53 million. 3,093.46 3,093.46 3,045.07 3,045.07 Total Shareholders’ Equity was Baht 1,541.88
has a list of liabilities under the lease agreement. Coming into the financial statements this year According to the financial reporting standard No. 16, it has resulted in increased liabilities in the
and the Net of current portion) increased by 123.4 MB because during Q2–2020, the Company entered into an additional financial arrangement agreement for a new project in which the supplier conditions